|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | How important is donor age in liver transplantation?显示文摘The age of liver donors has been increasing in the past several years because of a donor shortage. In the United States, 33% of donors are age 50 years or older, as are more than 50% in some European countries. The impact of donor age on liver transplantation(LT) has been analyzed in several studies with contradictory conclusions. Nevertheless, recent analyses of the largest databases demonstrate that having an older donor is a risk factor for graft failure. Donor age is included as a risk factor in the more relevant graft survival scores, such as the Donor Risk Index, donor age and Model for End-stage Liver Disease, Survival Outcomes Following Liver Transplantation, and the Balance of Risk. The use of old donors is related to an increased rate of biliary complications and hepatitis C virus-related graft failure. Although liver function does not seem to be significantly affected by age, the incidence of several liver diseases increases with age, and the capacity of the liver to manage or overcome liver diseases or external injuries decreases. In this paper, the importance of age in LT outcomes, the role of donor age as a risk factor, and the influence of aging on liver regeneration are reviewed. | Alberto Lué Estela Solanas Pedro Baptista Sara Lorente Juan J Araiz Agustin Garcia-Gil M Trinidad Serrano | 2016 | World Journal of Gastroenterology2016，22，21： | 10 |
| 2 | Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant显示文摘AIM: To investigate if conversion to the mammalian target of rapamycin inhibitors(mTORi) improves renal function in diabetic and/or hypertensive liver transplant patients immunosuppressed with tacrolimus or cyclosporine.METHODS: The study included 86 liver graft recipients immunosuppressed with mTORi treatment after orthotopic liver transplantation(OLT), including all liver recipients with worsening renal function before conversion to mTORi(n = 55 patients) and recipients with normal renal function who converted to m TORi for other reasons(n = 31 patients). We identified patients with diabetes mellitus(n = 28), arterial hypertension(n = 27), proteinuria(n = 27) and all three factors(n = 8)(some patients have hypertension and diabetes and no proteinuria). The primary endpoint was evolution in renal function defined as the development in plasma creatinine as a function of diabetes mellitus(DM), hypertension(HT) or proteinuria. We required elevated serum creatinine for at least two weeks to define renal dysfunction.RESULTS: Only patients that converted because of renal failure with plasma creatinine levels > 1.5 mg/dL showed an improvement of renal function(2.14 to 1.77 mg/dL)(P = 0.02). Patients with DM showed no improvement of serum creatinine levels(1.31 mg/dL to 1.37 mg/dL) compared with non DM patients(1.31 mg/dL to 1.15 mg/dL)(P = 0.01), HT patients(1.48 mg/dL to 1.5 mg/dL) with non HT patients(1.21mg/d L to 1.08 mg/dL) and patients with proteinuria(1.44 mg/dL to 1.41 mg/dL) and no proteinuria(1.31 mg/dL to 1.11 mg/dL). CONCLUSION: In OLT recipients with diabetes or hypertensive nephropathy, conversion to m TORi does not improve renal function but stabilizes plasma levels of creatinine. Proteinuria is not a contraindication to conversion to m TORi; it also stabilizes renal function. Conversion to m TORi should only be avoided in patients with diabetes, hypertension and proteinuria. | José M álamo Claudia Olivares Lydia Barrera Luis M Marín Gonzalo Suarez Carmen Bernal Juan Serrano Jordi Muntané Francisco J Padillo Miguel A Gómez | 2015 | World Journal of Transplantation2015，5，1： | 6 |
| 3 | The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy显示文摘 | Jose JG MARIN Maria J MONTE Alba G BLAZQUEZ Rocio IR MACIAS Maria A SERRANO Oscar BRIZ | 2014 | Acta Pharmacologica Sinica2014，35，1： | 4 |
| 4 | Biogeochemistry inNeves Corvo mining region,Iberian Pyrite Belt,Portugal显示文摘 | Batista M J Abreu M M Serrano P M | 2007 | Journal of Geochemical Exploration2007，92，23： | 3 |
| 5 | Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment显示文摘AIM: To describe the en bloc perfluorodissection(EBPD) technique and to demonstrate the applicabilityof using preoperative intravitreal bevacizumab duringsmall-gauge vitreoretinal surgery(23-gauge transconjunctival sutureless vitrectomy) in eyes with advancedproliferative diabetic retinopathy(PDR) with tractionalretinal detachment(TRD).METHODS: This is a prospective, interventional caseseries. Participants included 114(eyes) with advancedproliferative diabetic retinopathy and TRD. EBPD wasperformed in 114 eyes(consecutive patients) during23-gauge vitrectomy with the utilization of preoperativebevacizumab(1.25 mg/-0.05 mL). Patients mean age was 45 years(range, 21-85 years). Surgical time had a mean of 55 min(Range, 25-85 min). Mean follow up of this group of patients was 24 mo(range, 12-32 mo). Main outcome measures included best-corrected visual acuity(BCVA), retinal reattachment, and complications.RESULTS: Anatomic success occurred in 100%(114/-114) of eyes. Significant visual improvement [≥ 2 Early Treatment Diabetic Retinopathy Study(ETDRS) lines] was obtained in 69.2%(79/-114), in 26 eyes(22.8%) BCVA remained stable, and in 8 eyes(7%) BCVA decreased(≥ 2 ETDRS lines). Final BCVA was 20/-50 or better in 24% of eyes, between 20/-60 and 20/-400 in 46% of eyes, and worse than 20/-400 in 30% of eyes. Complications included cataract in 32(28%) eyes, iatrogenic retinal breaks in 9(7.8%) eyes, vitreous hemorrhage requiring another procedure in 7(6.1%) eyes, and phthisis bulbi in 1(0.9%) eye.CONCLUSION: This study demonstrates the usefulne-ss of using preoperative intravitreal bevacizumab and EBPD during smallgauge vitreoretinal surgery in eyes with TRD in PDR. | J Fernando Arevalo Martin A Serrano Juan D Arias | 2014 | World Journal of Diabetes2014，5，5： | 3 |
| 6 | Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct显示文摘 | Fontana Robert J Watkins Paul B Bonkovsky Herbert L Chalasani Naga Davern Timothy Serrano Jose Rochon James | 2009 | Drug Safety2009，，1： | 2 |
| 7 | Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors显示文摘 | Alexandre Andrade Anjos Jácome Durval R. Wohnrath Cristovam Scapulatempo Neto Estela C. Carneseca Sérgio V. Serrano Luciano Souza Viana Jo?o S. Nunes Edson Z. Martinez José Sebasti?o Santos | 2014 | Gastric Cancer2014，，1： | 2 |
| 8 | Microsatellite based genetic diversity and population structure of the en-dangered Spanish Guadarrama goat breed显示文摘 | Serrano M Calvo J H Martínez M | 2009 | BMC Genetics2009，10，： | 1 |
| 9 | Confocal mi-croscopy study of phase morphology evolution in epoxy/polysiloxanethermosets显示文摘 | Cabanelas J C Serrano B Gonzalez M G | 2005 | Polymer2005，46，： | 1 |
| 10 | Effect of corticosteroids on the clinical course of community - acquired pneumonia: a randomized controlled trial显示文摘 | Fernandez - Serrano S Dorca J Garcia - Vidal C | 2011 | Crti Care2011，15，2： | 1 |
| 11 | Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function 显示文摘 | Becker J Babb J Serrano M | 2013 | A JR Am J Roentgenol2013，200，4： | 1 |
| 12 | The glass transition and interfacial layer instyrene-butadiene rubber containing silica nanofiller 显示文摘 | Arrighi V MeEwen I J Qian H Serrano P M B | 2003 | Polymer2003，44，： | 1 |
| 13 | The role of free radicals in cerebral hypoxia and ischemia显示文摘 | Rodrigo J Femadez AP Serrano J | 2005 | Free Radic Biol Med2005，39，1： | 1 |
| 14 | Analysis of the capabilities of a two-stage turbocharging system to fulfil the US2007 anti-pollution directive for heavy duty diesel engines显示文摘 | Serrano J Amau F Dolz V | 2008 | International Journal of Automotive Technology2008，9，3： | 1 |
| 15 | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 显示文摘 | SERRANO M HANNON G J BEACH D | 2003 | Nature2003，366，6456： | 1 |
| 16 | Trend Analysis of Monthly PrecipitationOver the Iberian Peninsula for the Period 1921-1995显示文摘 | Serrano V L Mateos V L Garcia J A | 1999 | Physics and Chemis-try of the Earth:B1999，24，2： | 1 |
| 17 | Structural Study on Columnar Mesophases Consisting of H-Bonded Supramol- ecules显示文摘 | Barber6 J Puig L Serrano J L | 2004 | Chem Mater2004，16，： | 1 |
| 18 | Nanocrystalline ZSM-5:A catalyst with high activity and selectivity for epoxide rearrangement reactions显示文摘 | SERRANO D P VAN GRIEKEN R MELERO J A | 2010 | Journal of Molecular Catalysis A:Chemical2010，318，12： | 1 |
| 19 | Nasal and bronchial inflammation after nasal allergen challenge: assessment using noninvasive methods显示文摘 | Serrano CD Valero A Bartra J | 2012 | J Investig Allergol Clin Immunol2012，22，5： | 1 |
| 20 | Reduction of pomegranate chilling injury during storage after heat treatment: Role of polyamines显示文摘 | MIRDEHGHAN S H RAHEMIC M MARTINEZ-ROMERO D GUILLEN F VALVERDE J M ZAPATA P J SERRANO M VALERO D | 2007 | Postharvest Biology and Technology2007，44，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员